Evidence map›Paper›PMID 23262137›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2013

The myosin motor Myo1c is required for VEGFR2 delivery to the cell surface and for angiogenic signaling.

Ajit Tiwari, Jae-Joon Jung, Shivangi M Inamdar, Deepak Nihalani, Amit Choudhury

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. KIF13B mediates VEGFR2 recycling to modulate vascular permeability.Cellular and molecular life sciences : CMLS · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Targeting myosin 1c inhibits murine hepatic fibrogenesis.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ajit TiwariDepartment of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242, USA.
Jae-Joon Jung
Shivangi M Inamdar
Deepak Nihalani
Amit Choudhury
University of Iowa · USHospital of the University of Pennsylvania · US

Funding

Myo1c Participates in Podocyte Junction Formation Through Interaction with Neph1R01DK087956 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NIHALANI, DEEPAK · 2010 to 2018
$3.5M
Role of Syntaxin 6 Regulated Post-Golgi Trafficking in AngiogenesisR01HL089599 · NHLBI · UNIVERSITY OF IOWA · PI CHOUDHURY, AMIT · 2008 to 2012
$1.9M
NHLBI NIH HHS R01-HL-089599NIDDK NIH HHS R01 DK087956NIDDK NIH HHS R01-DK-087956
6 · The paper itself

Abstract

Vascular endothelial growth factor receptor-2 (VEGFR2) is a receptor tyrosine kinase that is expressed in endothelial cells and regulates angiogenic signal transduction under both physiological and pathological conditions. VEGFR2 turnover at the plasma membrane (PM) is regulated by its transport through endocytic and secretory transport pathways. Short-range cargo trafficking along actin filaments is commonly regulated by motor proteins of myosin superfamily. In the current study, performed in primary human endothelial cells, we demonstrate that unconventional myosin 1c (Myo1c; class I family member) regulates the localization of VEGFR2 at the PM. We further demonstrate that the recruitment of VEGFR2 to the PM and its colocalization with Myo1c and caveolin-1 occur in response to VEGF-A (VEGF) stimulation. In addition, VEGF-induced delivery of VEGFR2 to the cell surface requires Myo1c; surface VEGFR2 levels are reduced in the absence of Myo1c and, more importantly, are restored by the overexpression of wild-type but not mutant Myo1c. Subcellular density gradient fractionation revealed that partitioning of VEGFR2 into caveolin-1- and Myo1c-enriched membrane fractions is dependent on VEGF stimulation. Myo1c depletion resulted in increased VEGF-induced VEGFR2 transport to the lysosomes for degradation and was rescued by applying either brefeldin A, which blocks trafficking between the endoplasmic reticulum and the Golgi complex, or dynasore, an inhibitor of dynamin-mediated endocytosis. Myo1c depletion also reduced VEGF-induced VEGFR2 phosphorylation at Y1175 and phosphorylation-dependent activation of ERK1/2 and c-Src kinase, leading to reduced cell proliferation and cell migration. This is the first report demonstrating that Myo1c is an important mediator of VEGF-induced VEGFR2 delivery to the cell surface and plays a role in angiogenic signaling.

Indexed as

AntimalarialsBrefeldin ACaveolin 1Cell MembraneCell MovementCell ProliferationChloroquineEndocytosisEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsHydrazonesMembrane MicrodomainsMolecular Motor ProteinsMyosin Type INeovascularization, PhysiologicAntimalarialsBrefeldin ACAV1 protein, humanCaveolin 1ChloroquineHydrazonesMolecular Motor ProteinsMYO1C protein, humanMyosin Type IN'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazideProtein Synthesis InhibitorsRNA, MessengerVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID23262137
PMCPMC3602755
OpenAlexW2124325275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.